The trademark ALTAPHARM was filed by ATRILUX S.A., a corporation established under the laws of the Grand Duchy of Luxembourg (the "Applicant"). The application was published for oppositions on July 7, 2022, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on September 28, 2022 by Dirk Rossmann GmbH on Likelihood of confusion. the opponent was represented by HORAK. RECHTSANWÄLTE PARTNERSCHAFT MBB and its proceedings were handled in English The second opposition filed on August 17, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English
The application was filed in Spanish, and Spanish was also language of all opposition proceedings (English was selected as the second language).
Relative errors of the trademark registration was recorded on May 16, 2024.
The Opposition with reference B 003179702 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on December 20, 2023 by the EUIPO.